Ana de La Fuente Villena-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR

    International Journal of Cardiovascular Imaging, Vol. 39, Núm. 9, pp. 1765-1774

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12